Human retroviruses in health and disease.

Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Human retroviruses in health and disease.

Princess Takamatsu Symp. 1984;15:3-12. Unique Identifier : AIDSLINE MED/86111571
Weiss RA

Abstract: Before 1980, infectiously transmitted human retroviruses were unknown. Since then three types of human T-lymphotropic viruses (HTLVs) have been discovered and are under intensive study. Further types may well come to light. HTLV-I is etiologically associated with adult T-cell leukemia-lymphoma (ATLL), HTLV-II has been isolated from a patient with hairy T-cell leukemia, and HTLV-III is the cause of acquired immune deficiency syndrome (AIDS). Viruses related to HTLVs occur in several species of macaque monkeys. It appears that only a small minority of infected subjects develop the associated malignancy or immunodeficiency. Little is known of HTLV transmission, although it is clear that the viruses can be transmitted sexually and also iatrogenically through blood. HTLV-I and HTLV-II appear to be highly conserved across different human host populations, whereas HTLV-III shows greater polymorphism and elicits different immune responses. HTLVs have a tropism for T-helper/inducer cells. While HTLV-I and HTLV-II can penetrate many cell types and the T-cell tropism may reside in the activity of the X gene product following infection, initial infection of HTLV-III is restricted to cells bearing the T4 cell surface antigen. The T4 antigen is an essential component of the receptor for the virus, which is consistent with its tropism and the nature of the immunodeficiency it causes.

Keywords: Antibodies, Viral/ANALYSIS Cell Transformation, Neoplastic Human HTLV-BLV Viruses/IMMUNOLOGY/ISOLATION & PURIF/*PATHOGENICITY Receptors, Virus/ANALYSIS Retroviridae Infections/IMMUNOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLE REVIEW

860530
M8650223

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .